Glaucoma aggravated and Rash maculo-papular

Summary:

Rash maculo-papular is found among people with Glaucoma aggravated, especially for people who are male, 60+ old.

The study analyzes which people have Rash maculo-papular with Glaucoma aggravated. It is created by eHealthMe based on reports of 26 people who have Glaucoma aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Glaucoma aggravated?

Glaucoma aggravated (increased fluid pressure in the eye with vision loss) is found to be associated with 1,079 drugs and 304 conditions by eHealthMe. Check the latest studies of Glaucoma aggravated.

What is Rash maculo-papular?

Rash maculo-papular (red area on the skin that is covered with small confluent bumps) is found to be associated with 1,241 drugs and 1,535 conditions by eHealthMe. Check the latest studies of Rash maculo-papular.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

26 people who have Glaucoma Aggravated and Rash Maculo-Papular are studied.

Would you have Rash maculo-papular when you have Glaucoma aggravated?

Gender of people who have Glaucoma Aggravated and experienced Rash Maculo-Papular *:

female: 47.83 %
male: 52.17 %

Age of people who have Glaucoma Aggravated and experienced Rash Maculo-Papular *:

Common co-existing conditions for these people *:

High Blood Pressure: 13 people, 50.00%
High Blood Cholesterol: 6 people, 23.08%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 19.23%
Depression: 5 people, 19.23%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 19.23%
Fungal Infection: 4 people, 15.38%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 15.38%
Diabetes: 4 people, 15.38%
Cardiac Failure: 3 people, 11.54%
Multiple Myeloma (cancer of the plasma cells): 3 people, 11.54%

Common drugs taken by these people *:

Common symptoms for these people *:

Itching: 6 people, 23.08%
Eosinophilia (eosinophil count in the peripheral blood exceeds): 4 people, 15.38%
Rashes (redness): 4 people, 15.38%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 3 people, 11.54%
Fever: 3 people, 11.54%
Fatigue (feeling of tiredness): 3 people, 11.54%
Pneumonia: 2 people, 7.69%
Hypotension (abnormally low blood pressure): 2 people, 7.69%
Hypersensitivity: 2 people, 7.69%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Rash maculo-papular?

- Check whether Rash maculo-papular is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Rash maculo-papular and Glaucoma aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.